BPCE
TXG icon

Bank Pictet & Cie (Europe)’s 10x Genomics TXG Stock Holding History

Bank Pictet & Cie (Europe)’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-6,138
Closed -$343K – 264
2023
Q4 		$343K Sell
6,138
-233
-4% -$10.1K 0.01% 219
2023
Q3 		$263K Sell
6,371
-92
-1% -$4.79K 0.01% 228
2023
Q2 		$361K Sell
6,463
-252
-4% -$13.6K 0.01% 207
2023
Q1 		$375K Hold
6,715
– – 0.02% 141
2022
Q4 		$245K Buy
+6,715
New +$220K 0.01% 153
2022
Q2 		– Sell
-4,234
Closed -$322K – 179
2022
Q1 		$322K Buy
4,234
+428
+11% +$37.4K 0.01% 144
2021
Q4 		$567K Buy
3,806
+467
+14% +$71.5K 0.02% 127
2021
Q3 		$486K Sell
3,339
-309
-8% -$53.1K 0.02% 133
2021
Q2 		$714K Buy
3,648
+1,556
+74% +$282K 0.02% 115
2021
Q1 		$379K Buy
+2,092
New +$361K 0.02% 134

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Bank Pictet & Cie (Europe)'s TXG Position: Q1 2024 in Review

Bank Pictet & Cie (Europe) sold out of 10x Genomics (TXG) in Q1 2024, closing a stake of 6,138 shares — an estimated $343K sold.

Bank Pictet & Cie (Europe) first reported a position in TXG in Q1 2021 and held it in 10 quarters. The position peaked at $714K in Q2 2021. 290 funds tracked by Wall St. Rank hold TXG as of Q1 2024.

  • Bank Pictet & Cie (Europe) reported no remaining 10x Genomics position as of Q1 2024 after selling out during the quarter.
  • Bank Pictet & Cie (Europe) sold 6,138 10x Genomics shares in Q1 2024, an estimated $343K.
  • Bank Pictet & Cie (Europe) first reported a position in 10x Genomics in Q1 2021 and held it in 10 quarters.
  • Bank Pictet & Cie (Europe)'s 10x Genomics position peaked at $714K in Q2 2021.
  • 290 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2024.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q1 2024, filed 7 May 2024.